Itron (NASDAQ:ITRI - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a research report issued on Saturday.
Several other equities research analysts have also weighed in on ITRI. Stephens reissued an "equal weight" rating and issued a $130.00 price objective on shares of Itron in a report on Tuesday, October 7th. TD Cowen lifted their price objective on Itron from $139.00 to $145.00 and gave the stock a "buy" rating in a report on Friday, June 20th. JPMorgan Chase & Co. lifted their price objective on Itron from $145.00 to $155.00 and gave the stock an "overweight" rating in a report on Thursday. Zacks Research raised Itron from a "hold" rating to a "strong-buy" rating in a report on Tuesday. Finally, Guggenheim reissued a "buy" rating and issued a $155.00 price objective (up previously from $133.00) on shares of Itron in a report on Monday, July 14th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $138.10.
Get Our Latest Analysis on Itron
Itron Trading Down 2.2%
Shares of Itron stock opened at $131.33 on Friday. Itron has a 1 year low of $90.11 and a 1 year high of $140.04. The firm has a market cap of $6.00 billion, a PE ratio of 22.45, a P/E/G ratio of 0.74 and a beta of 1.48. The stock has a fifty day moving average price of $124.08 and a 200-day moving average price of $120.67. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.04 and a quick ratio of 1.75.
Itron (NASDAQ:ITRI - Get Free Report) last announced its earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.29. Itron had a return on equity of 19.69% and a net margin of 11.05%.The firm had revenue of $606.76 million during the quarter, compared to analyst estimates of $610.36 million. During the same period last year, the firm posted $1.21 EPS. The business's revenue was down .4% compared to the same quarter last year. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. Equities research analysts anticipate that Itron will post 5.33 EPS for the current year.
Insiders Place Their Bets
In other Itron news, CFO Joan S. Hooper sold 970 shares of the firm's stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $125.31, for a total value of $121,550.70. Following the completion of the transaction, the chief financial officer owned 88,394 shares in the company, valued at $11,076,652.14. This trade represents a 1.09% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Justin K. Patrick sold 388 shares of the firm's stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $125.31, for a total value of $48,620.28. Following the completion of the transaction, the senior vice president owned 20,761 shares of the company's stock, valued at approximately $2,601,560.91. This represents a 1.83% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 3,037 shares of company stock worth $380,566 over the last quarter. Insiders own 1.45% of the company's stock.
Institutional Inflows and Outflows
Large investors have recently added to or reduced their stakes in the stock. Twin Peaks Wealth Advisors LLC bought a new stake in shares of Itron during the 2nd quarter valued at about $30,000. Bessemer Group Inc. boosted its position in shares of Itron by 125.7% during the 2nd quarter. Bessemer Group Inc. now owns 255 shares of the scientific and technical instruments company's stock valued at $34,000 after acquiring an additional 142 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its position in shares of Itron by 343.6% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 346 shares of the scientific and technical instruments company's stock valued at $46,000 after acquiring an additional 268 shares during the last quarter. EverSource Wealth Advisors LLC boosted its position in shares of Itron by 25.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company's stock valued at $53,000 after acquiring an additional 81 shares during the last quarter. Finally, REAP Financial Group LLC boosted its position in shares of Itron by 168.4% during the 2nd quarter. REAP Financial Group LLC now owns 424 shares of the scientific and technical instruments company's stock valued at $56,000 after acquiring an additional 266 shares during the last quarter. Institutional investors own 96.19% of the company's stock.
About Itron
(
Get Free Report)
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Itron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.
While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.